Progression of vertebral fractures despite long-Term biochemical control of acromegaly: A prospective follow-up study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 12, 2013, Pages 4808-4815

  Claessen, K M J A ^a   Kroon, H M ^a   Pereira, A M ^a   Appelman Dijkstra, N M ^a   Verstegen, M J ^a   Kloppenburg, M ^a   Hamdy, N A T ^a   Biermasz, N R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; BONE DENSITY; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SPINE FRACTURE; SPINE RADIOGRAPHY; TRANSSPHENOIDAL SURGERY;

ACROMEGALY; AGED; BONE DENSITY; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; RISK FACTORS; SEX FACTORS; SPINAL FRACTURES; SPINE;

EID: 84889851725     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2695     Document Type: Review

References (38)

1. Giustina A, Mazziotti G, Canalis E. Growth hormone, insulin-like growth factors, and the skeleton. Endocr Rev. 2008;29(5):535-559.
2. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med. 2007;357(9):905-916.
3. Manelli F, Carpinteri R, Bossoni S, et al. Growth hormone in glucocorticoid-induced osteoporosis. Front Horm Res. 2002;30:174-183.
4. Ohlsson C, Bengtsson BA, Isaksson OG, Andreassen TT, Slootweg MC. Growth hormone and bone. Endocr Rev. 1998;19(1):55-79.
5. Bonadonna S, Mazziotti G, Nuzzo M, et al. Increased prevalence of radiological spinal deformities in active acromegaly: A cross-sectional study in postmenopausal women. J Bone Miner Res. 2005; 20(10):1837-1844.
6. Mazziotti G, Bianchi A, Bonadonna S, et al. Prevalence of vertebral fractures in men with acromegaly. J Clin Endocrinol Metab. 2008; 93(12):4649-4655.
7. Battista C, Chiodini I, Muscarella S, et al. Spinal volumetric trabecular bone mass in acromegalic patients: A longitudinal study. Clin Endocrinol (Oxf). 2009;70(3):378-382.
8. Biermasz NR, Hamdy NA, Pereira AM, Romijn JA, Roelfsema F. Long-term maintenance of the anabolic effects ofGHon the skeleton in successfully treated patients with acromegaly. Eur J Endocrinol. 2005;152(1):53-60.
9. BolanowskiM,Daroszewski J, MedraM,Zadrozna-Sliwka B. Bone mineral density and turnover in patients with acromegaly in relation to sex, disease activity, and gonadal function. J Bone Miner Metab. 2006;24(1):72-78.
10. Lesse GP, Fraser WD, Farquharson R, Hipkin L, Vora JP. Gonadal status is an important determinant of bone density in acromegaly. Clin Endocrinol (Oxf). 1998;48(1):59-65.
11. Scillitani A, Battista C, Chiodini I, et al. Bone mineral density in acromegaly: The effect of gender, disease activity and gonadal status. Clin Endocrinol (Oxf). 2003;58(6):725-731.
12. Seeman E, Wahner HW, Offord KP, Kumar R, Johnson WJ, Riggs BL. Differential effects of endocrine dysfunction on the axial and the appendicular skeleton. J Clin Invest. 1982;69(6):1302-1309.
13. Wassenaar MJ, Biermasz NR, Hamdy NA, et al. High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol. 2011; 164(4):475-483.
14. Madeira M, Neto LV, Torres CH, de Mendonça LM, Gadelha MR, de Farias ML. Vertebral fracture assessment in acromegaly. J Clin Densitom. 2013;16(2):238-243.
15. Holmes SJ, Shalet SM. Role of growth hormone and sex steroids in achieving and maintaining normal bone mass. Horm Res. 1996; 45(1-2):86-93.
16. Tuck SP, Francis RM. Testosterone, bone and osteoporosis. Front Horm Res. 2009;37:123-132.
17. Netelenbos JC, Lems WF, Geusens PP, et al. Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int. 2009;20(8):1347-1352.
18. Wassenaar MJ, Biermasz NR, van Duinen N, et al. High prevalence of arthropathy, according to the definitions of radiological and clinical osteoarthritis, in patients with long-term cure of acromegaly: A case-control study. Eur J Endocrinol. 2009;160(3):357-365.
19. Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F. Morbidity after long-term remission for acromegaly: Persisting jointrelated complaints cause reduced quality of life. J Clin Endocrinol Metab. 2005;90(5):2731-2739.
20. Biermasz NR, van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab. 2000;85(12):4596-4602.
21. Biermasz NR, Dekker FW, Pereira AM, et al. Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor 1 measurements. J Clin Endocrinol Metab. 2004;89(6):2789-2796.
22. Cole TJ. TheLMSmethod for constructing normalized growth standards. Eur J Clin Nutr. 1990;44(1):45-60.
23. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM. Plasma levels of insulin-like growth factor (IGF)-I, IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res. 1998;50(3):166-176.
24. Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8(9):1137-1148.
25. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complications of acromegaly: Epidemiology, pathogenesis, and management. Endocr Rev. 2004;25(1):102-152.
26. Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP. Mortality in acromegaly: A metaanalysis. J Clin Endocrinol Metab. 2008;93(1):61-67.
27. Wassenaar MJ, Biermasz NR, Kloppenburg M, et al. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients. Growth Horm IGF Res. 2010;20(3):226-233.
28. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int. 2000;11(8):680-687.
29. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, Berger M. Patients with prior fractures have an increased risk of future fractures: A summary of the literature and statistical synthesis. J Bone Miner Res. 2000;15(4):721-739.
30. Mazziotti G, Bianchi A, Porcelli T, et al. Vertebral fractures in patients with acromegaly: A 3-year prospective study. J Clin Endocrinol Metab. 2013;98(8):3402-3410.
31. Van Staa TP, Laan RF, Barton IP, Cohen S, Reid DM, Cooper C. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy. Arthritis Rheum. 2003;48(11):3224-3229.
32. Ueland T, Ebbesen EN, Thomsen JS, et al. Decreased trabecular bone biomechanical competence, apparent density, IGF-II and IGFBP-5 content in acromegaly. Eur J Clin Invest. 2002;32(2):122-128.
33. Dall'Ara E, Schmidt R, Zysset P. Microindentation can discriminate between damaged and intact human bone tissue. Bone. 2012;50(4): 925-929.
34. Bonds DE, Larson JC, Schwartz AV, et al. Risk of fracture in women with type 2 diabetes: The Women's Health Initiative Observational Study. J Clin Endocrinol Metab. 2006;91(9):3404-3410.
35. Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM. Bone loss and bone turnover in diabetes. Diabetes. 1995;44(7):775-782.
36. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med. 1991;114(11):919-923
37. Nevitt MC, Ross PD, Palermo L, Musliner T, Genant HK, Thompson DE. Association of prevalent vertebral fractures, bone density, and alendronate treatment with incident vertebral fractures: Effect of number and spinal location of fractures. The Fracture Intervention Trial Research Group. Bone. 1999;25(5):613-619.
38. Black DM, Arden NK, Palermo L, Pearson J, Cummings SR. Prevalent vertebral deformities predict hip fractures and new vertebral deformities but not wrist fractures. Study of Osteoporotic Fractures Research Group. J Bone Miner Res. 1999;14(5):821-828.